Page last updated: 2024-11-04

terbutaline and Hyperkalemia

terbutaline has been researched along with Hyperkalemia in 8 studies

Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.

Hyperkalemia: Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed)

Research Excerpts

ExcerptRelevanceReference
" Although rebound hyperkalemia after cessation of tocolytic therapy with ritodrine has been reported, there have been no reports of hyperkalemia occurring after the cessation of beta-adrenergic tocolytic therapy with terbutaline for preterm labor; we report such a case."7.72Rebound hyperkalemia after cessation of intravenous tocolytic therapy with terbutaline in the treatment of preterm labor: anesthetic implications. ( Benumof, JL; Kuczkowski, KM, 2003)
"Administration of subcutaneous terbutaline obviates the need for intravenous access and should be considered as an alternative to nebulized or inhaled beta-agonists to treat acute hyperkalemia in patients with CKD."5.11Subcutaneous terbutaline use in CKD to reduce potassium concentrations. ( Cronin, D; Kraus, MA; Mueller, BA; Sowinski, KM, 2005)
" To control hypertension and chronic heart failure he had been treated with 5 mg ramipril and 12."3.73[A patient with severe hyperkalaemia -- an emergency after RALES]. ( Daul, A; Nürnberger, J; Philipp, T, 2005)
" Although rebound hyperkalemia after cessation of tocolytic therapy with ritodrine has been reported, there have been no reports of hyperkalemia occurring after the cessation of beta-adrenergic tocolytic therapy with terbutaline for preterm labor; we report such a case."3.72Rebound hyperkalemia after cessation of intravenous tocolytic therapy with terbutaline in the treatment of preterm labor: anesthetic implications. ( Benumof, JL; Kuczkowski, KM, 2003)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19904 (50.00)18.7374
1990's0 (0.00)18.2507
2000's3 (37.50)29.6817
2010's0 (0.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Hepps Keeney, CM1
Gorges, MA1
Gremling, MM1
Chinnadurai, SK1
Harrison, TM1
Kuczkowski, KM1
Benumof, JL1
Sowinski, KM1
Cronin, D1
Mueller, BA1
Kraus, MA1
Nürnberger, J1
Daul, A1
Philipp, T1
Surrow, J1
Sjølin, SU1
Olsson, AM1
Persson, S1
Schöder, R1
Tanaka, Y1
Nagao, M1
Nishio, T1
Hashida, E1
Kashiwagi, A1
Shigeta, Y1
Djurhuus, S1
Rohold, A1
Medici, R1
Vadstrup, S1

Trials

1 trial available for terbutaline and Hyperkalemia

ArticleYear
Subcutaneous terbutaline use in CKD to reduce potassium concentrations.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005, Volume: 45, Issue:6

    Topics: Adrenergic beta-Agonists; Adult; Body Weight; Female; Heart Rate; Humans; Hyperkalemia; Injections,

2005

Other Studies

7 other studies available for terbutaline and Hyperkalemia

ArticleYear
HYPERKALEMIA IN FOUR ANESTHETIZED RED WOLVES (
    Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2023, Volume: 54, Issue:2

    Topics: Anesthetics; Animals; Butorphanol; Hyperkalemia; Ketamine; Terbutaline; Wolves

2023
Rebound hyperkalemia after cessation of intravenous tocolytic therapy with terbutaline in the treatment of preterm labor: anesthetic implications.
    Journal of clinical anesthesia, 2003, Volume: 15, Issue:5

    Topics: Adult; Anesthesia, Obstetrical; Arrhythmias, Cardiac; Female; Humans; Hyperkalemia; Infusions, Intra

2003
[A patient with severe hyperkalaemia -- an emergency after RALES].
    Deutsche medizinische Wochenschrift (1946), 2005, Sep-09, Volume: 130, Issue:36

    Topics: Acute Kidney Injury; Adrenergic beta-Agonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-

2005
[Terbutaline treatment of familial hyperkalemic periodic paralysis].
    Ugeskrift for laeger, 1984, Sep-03, Volume: 146, Issue:36

    Topics: Adolescent; Adult; Aged; Child; Female; Humans; Hyperkalemia; Male; Paralyses, Familial Periodic; Te

1984
Effects of terbutaline and isoproterenol on hyperkalemia in nephrectomized rabbits.
    Scandinavian journal of urology and nephrology, 1978, Volume: 12, Issue:1

    Topics: Animals; Blood Pressure; Drug Evaluation, Preclinical; Heart Rate; Hyperkalemia; Isoproterenol; Neph

1978
[A new treatment of hyperkalemia in renal failure with selective beta 2-adrenergic stimulant, terbutaline sulfate].
    Nihon Jinzo Gakkai shi, 1989, Volume: 31, Issue:4

    Topics: Adult; Aged; Female; Humans; Hyperkalemia; Infusions, Intravenous; Kidney Failure, Chronic; Male; Mi

1989
[Hyperkalemia precipitated by beta 2 receptor agonists].
    Ugeskrift for laeger, 1986, Apr-07, Volume: 148, Issue:15

    Topics: Aged; Albuterol; Asthma; Female; Humans; Hyperkalemia; Terbutaline

1986